Proto Labs, Inc. $PRLB Shares Newly Acquired by Bank of America Corp DE

Key Points

• Bank of America acquired 125,997 Proto Labs shares during the second quarter, worth approximately $10.27 million and representing about 0.53% of the company. Institutional investors and hedge funds collectively own 84.54% of PRLB.
• Proto Labs exceeded quarterly expectations, reporting $0.60 earnings per share versus a $0.53 consensus estimate and revenue of $149.34 million, up 10.5% year over year. The company issued third-quarter EPS guidance of $0.56 to $0.64.
• PRLB shares opened at $96.19, near their 52-week high of $96.92, while analysts maintain a consensus “Buy” rating with an average price target of $89.00. CFO Daniel Schumacher recently sold 5,000 shares under a pre-arranged trading plan.

Bank of America Corp DE purchased a new position in Proto Labs, Inc. (NYSE:PRLB - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 125,997 shares of the industrial products company's stock, valued at approximately $10,270,000. Bank of America Corp DE owned approximately 0.53% of Proto Labs at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of PRLB. American Capital Management Inc. acquired a new position in Proto Labs during the second quarter worth $50,524,000. Jupiter Topco LLC purchased a new position in Proto Labs during the second quarter worth about $996,000. Hsbc Holdings PLC purchased a new position in Proto Labs during the second quarter worth about $2,005,000. Canada Pension Plan Investment Board acquired a new position in Proto Labs in the 2nd quarter valued at about $774,000. Finally, Legal & General Group Plc acquired a new position in Proto Labs in the 2nd quarter valued at about $4,625,000. 84.54% of the stock is currently owned by institutional investors and hedge funds.

Proto Labs Stock Performance

Shares of PRLB stock opened at $96.19 on Friday. The firm's 50 day moving average price is $82.85 and its 200-day moving average price is $73.70. Proto Labs, Inc. has a one year low of $45.10 and a one year high of $96.92. The firm has a market cap of $2.30 billion, a P/E ratio of 76.95 and a beta of 1.42.

Proto Labs (NYSE:PRLB - Get Free Report) last posted its earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.07. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The firm had revenue of $149.34 million during the quarter, compared to the consensus estimate of $144.53 million. During the same quarter last year, the firm earned $0.41 EPS. The firm's revenue for the quarter was up 10.5% on a year-over-year basis. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. As a group, research analysts predict that Proto Labs, Inc. will post 1.46 EPS for the current fiscal year.

Insider Activity

In related news, CFO Daniel Schumacher sold 5,000 shares of the stock in a transaction dated Thursday, September 24th. The stock was sold at an average price of $95.32, for a total transaction of $476,600.00. Following the transaction, the chief financial officer owned 35,019 shares of the company's stock, valued at approximately $3,338,011.08. This represents a 12.49% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 10,000 shares of company stock valued at $902,629. 1.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

PRLB has been the subject of a number of recent analyst reports. Benchmark raised their price target on shares of Proto Labs from $70.00 to $91.00 and gave the stock a "buy" rating in a report on Thursday, July 2nd. Weiss Ratings cut Proto Labs from a "buy (b)" rating to a "buy (b-)" rating in a report on Friday, September 18th. Wall Street Zen lowered Proto Labs from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 18th. Zacks Research raised Proto Labs from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 6th. Finally, Needham & Company LLC upgraded Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 target price on the stock in a research report on Monday, August 3rd. One equities research analyst has rated the stock with a Strong Buy rating and three have assigned a Buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $89.00.

Proto Labs Profile

Proto Labs, Inc NYSE: PRLB, doing business as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. Its platform enables engineers and product developers to upload three-dimensional computer-aided design files, receive automated design analyses and quotes, and order custom parts through a streamlined online process.

The company offers computer numerical control machining, injection molding, 3D printing and sheet-metal fabrication.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.